top of page

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

FoodBev Media Logo

Search results for "DSM-Firmenich"

113 results found for "DSM-Firmenich"

  • DSM-Firmenich reaches 100% renewable electricity target

    DSM-Firmenich has announced that it has met its goal of sourcing 100% of its purchased electricity from Dimitri de Vreeze, CEO of DSM-Firmenich, said: “Reaching 100% purchased renewable electricity ahead of To achieve this goal, DSM-Firmenich implemented a sourcing strategy aligned with RE100, a global initiative In addition to achieving 100% renewable electricity, DSM-Firmenich is exploring renewable steam and heat Featured image: © DSM-Firmenich

  • DSM-Firmenich invests $10m to modernise Schenectady premix hub in the US

    DSM-Firmenich has completed a $10 million upgrade of its premix facility in Schenectady, New York, positioning According to DSM-Firmenich, the investment reflects increasing regulatory scrutiny and growing customer Maximilian Fattinger, vice president of premix at DSM-Firmenich, said: “This investment goes well beyond Headquartered in Switzerland and the Netherlands, DSM-Firmenich operates in nearly 60 countries and reported

  • DSM-Firmenich increases stake in Andre Pectin to 90.5%

    DSM-Firmenich has solidified its position in the specialty food ingredient sector by increasing its shareholding in Yantai DSM Andre Pectin Company Limited (Andre Pectin) to 90.5%. This acquisition is part of DSM-Firmenich's broader strategy to expand its portfolio in nutrition and The increased ownership allows DSM-Firmenich to enhance its operational control and innovation capabilities

  • Cosaic secures $6m seed funding led by DSM-Firmenich Ventures

    Food-tech start-up Cosaic has announced a successful $6 million seed funding round, led by DSM-Firmenich In addition to DSM-Firmenich Ventures, the round saw participation from Swiss deep-tech investor Kickfund Backing from major players like Ingredion and DSM-Firmenich is helping to accelerate the company’s path

  • DSM-Firmenich partners with AI specialist to accelerate flavour molecule discovery

    DSM-Firmenich is partnering with AI company Boltz PBC to accelerate the discovery and development of The partnership will see Boltz’s biomolecular foundation models integrated into DSM-Firmenich’s ingredient The companies aim to combine AI-driven molecular modelling with DSM-Firmenich’s extensive library of The collaboration will result in a set of exclusive models designed around DSM-Firmenich’s expertise Researchers from Boltz will also work alongside DSM-Firmenich scientists as part of the collaboration

  • DSM-Firmenich offloads yeast business to Lesaffre

    DSM-Firmenich has agreed to sell its yeast extract business, Yeast Extracts, to fermentation and microorganism Yeast Extracts is part of DSM-Firmenich's Taste, Texture & Health business unit and has annual sales As part of DSM-Firmenich's portfolio optimisation, the company de-prioritised certain business segments Under the transaction, Lesaffre will enter into an agreement to supply yeast extracts to DSM-Firmenich Some of the DSM-Firmenich employees working on Yeast Extracts will transfer to Lesaffre.

  • DSM-Firmenich introduces ModulaSense maskers for plant protein applications

    DSM-Firmenich has launched a new line of ModulaSense maskers aimed at improving the sensory profiles By enhancing the taste profile of RTM drinks and protein bars, DSM-Firmenich aims to support the industry Alejandra Camacho, vice president and global innovation leader for dairy taste and plant-based at DSM-Firmenich

  • DSM-Firmenich proposes Richard Ridinger as new chairman as Thomas Leysen steps down

    DSM-Firmenich’s chair of the board of directors, Thomas Leysen (pictured above), has decided to retire DSM-Firmenich praised his deep understanding of the company, positioning him well to succeed Leysen. Since the formation of DSM-Firmenich, a result of the merger between Royal DSM and Firmenich in 2023, Leysen commented: “With DSM-Firmenich now fully operating as one company, the portfolio tuning nearing “Richard has all the requisite experience to help bring DSM-firmenich to the next level.

  • DSM-Firmenich revamps executive committee to drive growth in nutrition and health

    DSM-Firmenich has announced significant changes to its executive committee, effective today (Monday 1 In a move that underscores its commitment to innovation, DSM-Firmenich will welcome Alessandre Keller Clementi, who has been with DSM-Firmenich for 14 years, is recognised for his expertise in taste innovation As DSM-Firmenich prepares for the final stages of its animal nutrition and health (ANH) carve-out, Ivo Dimitri de Vreeze, CEO of DSM-Firmenich, expressed enthusiasm about the new appointments: “Both Alessandre

  • Biospringer by Lesaffre acquires ModuMax taste modulation tech from DSM-Firmenich

    2026) announced its acquisition of ModuMax, a portfolio of taste modulation solutions developed by DSM-Firmenich

  • DSM-Firmenich expands Indonesia operations with new Jakarta office and Karawang capabilities

    DSM-Firmenich has opened a new office in Jakarta and expanded its Karawang manufacturing facility in The new Jakarta office brings together teams from DSM-Firmenich’s three business units – Taste, Texture Timothy Elisafan, VP of Taste, Asia Pacific at DSM Firmenich, said: “Indonesia has been an important Alongside the Jakarta office opening, DSM-Firmenich has completed an expansion of its Karawang manufacturing Both sites were officially inaugurated this week, with DSM-Firmenich CEO Dimitri de Vreeze; Taste, Texture

  • DSM-Firmenich wins lawsuit protecting algal oil patent

    DSM-Firmenich has won its patent infringement case against Canada-based Mara Renewables Corporation and Patent No. 10,392,578, protects DSM-Firmenich's innovations in providing nutritional lipids rich in docosahexaenoic Francois Scheffler, executive vice president of global marketing and business development of DSM-Firmenich Business Unit, said: “This result confirms our contentions that Mara/AO3 has been unlawfully using DSM-Firmenich The intellectual property at the heart of the litigation protects DSM-Firmenich's advances in biotechnology

Search Results

bottom of page